Authors:Mughal Qayum, Muhammad Nisar, Abdur Rauf, Imran Khan, Waqar Ahmad Kaleem, Muslim Raza, Nasiara Karim, Munawar Ahmad Saleem, Saud Bawazeer, Sengul Uysal, Gokhan Zengin, Saqib Jahan and Mohamed Fawzy Ramadan
Natural products derived from medicinal plants provide beneficial cancer chemotherapeutic drugs. Bioactive constituents from plants are explored for their anticancer properties.
Three known compounds (deacetylbaccatin III, tasumatrol B, and taxawallin J) were isolated from Taxus wallichiana. Compounds were screened against four cancer cell lines, such as eA498, HepG2, NCI-H226, and MDR 2780AD. Cytotoxic activity was evaluated using MTT assay against cancer cell lines.
Tasumatrol B showed good cytotoxic activity conducted for the improvement of inhibiting potential of these compounds against the cancer drug target protein (EGFR tyrosine kinase enzyme). The docking study showed that all compounds have binding affinities and interaction profile with the receptor tyrosine kinase.
The study suggests that these compounds could be used for the discovery of novel inhibitors against the target receptors for the treatment of cancer.